ZimVie

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie recently announced that management will participate in the upcoming UBS Global Healthcare Conference....

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, announced...

ZimVie Announces FDA Clearance and United States Launch of GenTek Restorative Components

ZimVie announced the U.S. launch of its GenTek Genuine Restorative Components product portfolio. The...

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

ZimVie announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference....

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine...

ZimVie Announces Definitive Agreement to Sell Spine Business

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine...

ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors

ZimVie announced its debut as an independent publicly traded company and the completion of...